KILITCH DRUGS (INDIA)
Back to Cashflow Statement
|
KILITCH DRUGS (INDIA) Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹82 Cr | ₹13 Cr | ₹8.81 Cr | ₹-0.72 Cr | ₹7.03 Cr |
What is the latest Cash Flow from Financing Activities ratio of KILITCH DRUGS (INDIA) ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹82 Cr |
| Mar2025 | ₹13 Cr |
| Mar2024 | ₹8.81 Cr |
| Mar2023 | ₹-0.72 Cr |
| Mar2022 | ₹7.03 Cr |
How is Cash Flow from Financing Activities of KILITCH DRUGS (INDIA) Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹82 Cr | 522.62 | |
| Mar2025 | ₹13 Cr | 50.37 | |
| Mar2024 | ₹8.81 Cr | Positive | |
| Mar2023 | ₹-0.72 Cr | Negative | |
| Mar2022 | ₹7.03 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KILITCH DRUGS (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KILITCH DRUGS (INDIA) | ₹750.9 Cr | 6.1% | -4% | 11% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
KILITCH DRUGS (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KILITCH DRUGS (INDIA) | 6.1% |
-4% |
11% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses